QLS5308

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS5308, covering 2026-03-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of QLS5308 in Patients With Advanced Solid Tumors [Phase 1]